My ePortfolio Register   
 

Abstract | Full HTML Article | PDF | Portuguese | Spanish ecancer 11 716 / DOI: 10.3332/ecancer.2017.716

Policy

Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group

Neuroendocrine tumours are a heterogeneous group of diseases with a significant variety of diagnostic tests and treatment modalities. Guidelines were developed by North American and European groups to recommend their best management. However, local particularities and relativisms found worldwide led us to create Brazilian guidelines. Our consensus considered the best feasible strategies in an environment involving more limited resources. We believe that our recommendations may be extended to other countries with similar economic standards.

Keywords: neuroendcrine tumours, cancer, chemotherapy, targeted therapy, radionuclide peptide therapy, guideline

Loading Article Metrics ... Please wait

Related articles

Case Report: Resection of rectal GIST using a novel technique: a report of two cases

Abstract | Full Article | PDF Published: 17 Aug 2017 / DOI: 10.3332/ecancer.2017.760

Case Report: Metastasizing pleomorphic adenoma of the parotid gland

Abstract | Full Article | PDF Published: 15 Aug 2017 / DOI: 10.3332/ecancer.2017.758

Review: Cancer of childhood in sub-Saharan Africa

Abstract | Full Article | PDF Published: 28 Jul 2017 / DOI: 10.3332/ecancer.2017.755

Research: Clinical, epidemiological, and therapeutic profile of patients with a retinoblastoma diagnosis experience in the Costa Rica National Children’s Hospital Oncology Unit from January 2009 to December 2015

Abstract | Full Article | PDF Published: 24 Jul 2017 / DOI: 10.3332/ecancer.2017.754

Research: Pregnancy testing in patients undergoing radiation therapy

Abstract | Full Article | PDF Published: 19 Jul 2017 / DOI: 10.3332/ecancer.2017.753



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence